TrialClinical pharmacology in drug development2017

Safety, Tolerability, and Pharmacokinetics of ARC-520 Injection, an RNA Interference-Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers.

Thomas Schluep et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.